Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian Cancer

NCT07589543 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Epithelial Ovarian Cancer
Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum

Interventions

BIOLOGICAL: EB-DUALNK
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

Beijing Biotech